Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
暂无分享,去创建一个
Nurcan Tuncbag | A. Cribbs | T. Onder | Tunc Morova | N. Lack | H. Timmers | M. Biniossek | Ceyda Acilan | I. Bulut | T. Bagci-Onder | Fidan Seker-Polat | S. Nizamuddin | Ezgi Yagmur Kala | A. C. Aksu | Ezgi Ozyerli-Goknar | Ahmet Cingöz | Hamzah Syed | M. Philpott | Sonia H. Y. Kung | Can Aztekin | Mehmet Gönen